Clinical Trials Browser

Phase 2 × selinexor × Endocrine × Clear all

NCT02250885 2019-09-17

KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors

Phase 2 Completed

Carcinoma, Neuroendocrine